Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | CES2 | O00748 | 2/20 | 0.55 |
| ▸ | CES1 | P23141 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 6/20 | 0.53 |
| ▸ | CA2 | P00918 | 6/20 | 0.53 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.52 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.52 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.52 |
| ▸ | PLK1 | P53350 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL756485 | 0.86 | NR1I2 (0.56) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL4196144 | 0.85 | CA1 (0.62) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL3382989 | 0.80 | ALDH1A1 (0.48) | MAPTCES2CES1GSK3BMEN1 | |
| SCHEMBL4998485 | 0.80 | CA1 (0.67) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL5082856 | 0.79 | CES2 (0.61) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL8760128 | 0.78 | CES2 (0.46) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL28586063 | 0.78 | CA1 (0.64) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL280538 | 0.78 | ELANE (0.47) | MAPTCES2CES1LMNANPSR1 | |
| SCHEMBL10872940 | 0.77 | CA1 (0.56) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL16220971 | 0.77 | CA1 (0.62) | MAPTCES2CES1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1329497-B1 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH & CIE (CH) | 2010-12-01 | — | — | EP | claimed |
| US-7129206-B2 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2006-10-31 | — | — | US | claimed |
| US-20030144173-A1 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-31 | — | — | US | claimed |
| EP-1329497-A2 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-23 | — | — | EP | claimed |
| EP-1329497-B1 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH & CIE (CH) | 2010-12-01 | — | — | EP | disclosed |
| US-7129206-B2 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2006-10-31 | — | — | US | disclosed |
| US-20030144173-A1 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-31 | — | — | US | disclosed |
| EP-1329497-A2 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144173-A1 | Utilization of unsaturated esters as perfuming ingredients | CPT1A, FASN, FFAR3 | MAPT 3557/4885CES2 1087/4885CES1 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.